louisakewell, Author at European Medical Journal - Page 101 of 153

Continue
EMJ
1 Mins
24th August 2015

Long-Term Survival Rates Sufficient for Bladder Cancer Patients Treated With Robotic Surgery

PATIENTS diagnosed with bladder cancer (BLC) and treated with robot-assisted surgery experience similar results to those who undergo a traditional open…
EMJ
21st August 2015

Therapy for newly diagnosed patients with mantle cell lymphoma

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses new…
EMJ
21st August 2015

Introducing biomarkers for the management of patients with prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center…
EMJ
21st August 2015

CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with breast cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides…
EMJ
21st August 2015

Developing targeted therapies for melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…
EMJ
4 Mins
21st August 2015

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…
EMJ
1 Mins
17th August 2015

More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip

PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.
EMJ
1 Mins
17th August 2015

Disabling Ability of Lymphoma to Escape Immune Response May Trigger New Treatments

RESTORING the power of natural killer (NK) cells in the vicinity of lymphoma tumours may catalyse the development of new therapies, according to…
13th August 2015

Bruce Culleton: The Latest Developments in Home Dialysis

An interview with Dr Bruce Culleton discussing HOMECHOICE CLARIA, SHARESOURCE and VIVIA at ERA-EDTA 2015.
EMJ
13th August 2015

Predicting late recurrence of breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Eleftherios P. Mamounas, MD, of University of Florida Health Cancer Center-Orlando…